The https://www.regulations.gov electronic filing system will accept comments until midnight Eastern Time at the end of April 23, 2018.
WHO will convene in a special session to review the following substances: Cannabis plant and resin; extracts and tinctures of cannabis; delta-9-tetrahydrocannabinol (THC; stereoisomers of THC; and cannabidiol (CBD).
As required by paragraph (d)(2)(A) of the CSA, FDA, on behalf of HHS, invites interested persons to submit comments regarding the five drug substances.
Your turn homies! I kept mine short and sweet. If someone feels particularly articulate and expressive feel free to write a submission template for Future4200 users to copy pasta. I know mine isn’t perfect but better than nothing!